Management of Hyperacute Amiodarone-induced Pulmonary Toxicity

One of the major complications of amiodarone therapy is acute pulmonary toxicity (APT). Patients tend to have amiodarone-induced toxicity after Coronary Artery Bypass Surgery (CABG). For this reason, priority should be given to the treatment of this fatal complication. Acute pulmonary toxicity due to amiodarone is a treatable phenomenon if diagnosed early, for this reason, meticulous follow-up and suspicion are of great importance. We describe the treatment of a 72-year-old male with amiodarone-induced pulmonary toxicity immediately after amiodarone infusion who underwent 4-vessel coronary artery bypass grafting surgery.